AIBN researchers have secured a major grant to position lignin as a key plank in the $15 billion market for sustainable rubbers, adhesives, and coatings.
With the support of the Lily Foundation, University of Cambridge Neurologist Dr Jelle van den Ameele and AIBN group leader Dr Seth Cheetham are hoping to change the fortunes of those born with a fatal condition.
A new facility at the Australian Institute for Bioengineering and Nanotechnology is set to provide researchers with cancer vaccines tailored to individual patients.
A new parcel of federal funding will help AIBN researchers produce clinical-grade mRNA products that are safer and better quality, and will potentially cost less.
By feeding waste gases like carbon dioxide, carbon monoxide, and methane to certain bacteria, Antonia Ebert is producing bioplastics that break down naturally in the environment.
A blue-sky vision for a new, durable green polymer has won AIBN researchers global recognition at the 2024 Serendipity Collective competition in Estonia.